In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1832 News Items found
Ask the Expert
Radiation oncologist and CyberKnife expert Abraham Wu
Why Am I Hearing So Much About CyberKnife?

CyberKnife is a brand name for one of several available stereotactic radiosurgery devices that deliver radiation with linear accelerators. MSK uses a similar device, made by a company called Varian, that destroys tumors with extremely precise, very intense doses of radiation.
Profile
Simon Powell
Meet Radiation Oncologist Simon Powell

Simon Powell leads the Department of Radiation Oncology and focuses in his research on the treatment of breast cancer, including the role of DNA repair deficiencies in breast cancer and breast cancer genetics.
Ask the Expert
Pharmacist and herbalist Simon Yeung
How do I know if a dietary supplement contains what the label says it contains?

Pharmacist and herbalist Simon Yeung gives consumers tips on how to determine whether an herb or dietary supplement contains what’s indicated on the label.
Announcement
Pictured: Jedd Wolchok & Alexander Rudensky
Memorial Sloan Kettering Shares Historic Gift to Fund Immunotherapy Research

Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer.
In the Lab
Pictured: Stem cell-derived nerve cells exposed to progerin
Researchers Fast-Forward Stem Cell Aging to Study Degenerative Diseases

A team of Memorial Sloan Kettering scientists has come up with an approach to make stem-cell-derived neurons rapidly age in a cell culture dish. The breakthrough could transform research into Parkinson’s and other late-onset diseases.
In Memoriam
Cancer research pioneer Janet Rowley
Memorial Sloan Kettering Mourns the Death of Cancer Research Pioneer Janet Rowley

Memorial Sloan Kettering President and CEO Craig Thompson reflects on the life and career of cancer research pioneer Janet Rowley.
Profile
Pictured: Alexander Rudensky
At Work: Immunologist Alexander Rudensky

Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors.
In the Lab
Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.
In the News
New Biotech Startup Will Pit the Immune System Against Cancer

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.
Announcement
Pictured: Michael Foley
Michael Foley Named Director of Tri-Institutional Therapeutics Discovery Institute

A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.